UL Solutions reports second-quarter results on July 31 against a backdrop of sharply higher short interest, cautious options positioning, and a stock that just clawed back some of a painful month.
The most striking setup detail is the surge in short positioning. Short interest has nearly doubled over the past month — up 91% — to reach 7.3% of the free float, a level meaningful enough to command attention ahead of a print. That build happened fast: from roughly 2.5 million shares short in mid-June to 4.55 million by July 24. Despite that, the borrow market remains far from stressed. Availability is ample at roughly 483% — meaning there are nearly five shares available to lend for every share currently borrowed — and the cost to borrow is a negligible 0.54%, down modestly on the month. The rapid short build looks more like fresh conviction than a squeeze-prone crowded trade. Options positioning reinforces the defensive lean: the put/call ratio has run well above its recent average, sitting near 2.72 versus a 20-day mean of 1.61, pushed higher as traders loaded puts through the back half of July. The stock itself recovered 5% on the day and over the week to close at $90.06, but remains down 9% over the past month — the bounce comes off a weak base.
The analyst community is genuinely divided on how much premium UL Solutions deserves. UBS upgraded the stock to Buy on July 14, keeping its $110 target in place — a signal that at least one bellwether firm sees the recent selloff as an entry point. Wells Fargo carries the highest published target at $120, reflecting the bull case: UL Solutions is the global brand standard in testing, inspection, and certification, with a structural moat in a fragmented industry and strong growth metrics — the forward EPS estimate trend ranks in the 90th percentile of the ORTEX universe on year-on-year improvement. Bears point to a more complicated picture: regulatory frameworks are shifting in ways that could reduce mandatory certification demand, China (roughly 24% of revenue) is an ongoing geopolitical exposure, and valuation is not forgiving at 34.8x trailing earnings and nearly 19x EV/EBITDA. The P/B multiple has compressed about 15% over the past month, suggesting the market has already started repricing risk, but the stock is still not cheap on an absolute basis.
Institutional ownership adds an interesting wrinkle. T. Rowe Price added over 2 million shares through June, one of the larger disclosed additions among the top holders. BlackRock added 455,000 shares in the same period. That institutional accumulation sits alongside CEO Jennifer Scanlon selling approximately $1.2 million of stock on July 1 — a cluster of smaller transactions across multiple price points in the high $90s and low $100s, all above today's $90 close. The insider sales are modest relative to the CEO's stake and carry low significance scores, but the direction is worth noting when the stock trades below the prices at which the CEO was trimming.
Thursday's print will test whether UL Solutions's growth credentials — widely acknowledged by the Street — can hold up against the China uncertainty and regulatory risk that the bears have been pricing in through June and July.
See the live data behind this article on ORTEX.
Open ULS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
